Since our beginnings in 2016, End points New has grown rapidly while delivering on our mission to cover the most critical developments in biopharma for industry professionals worldwide. As the readership grew, so did our advertising activity. Endpoints advertising partners support the mission and engage their desired audiences through advertisements on our email and web platforms, brand recognition in our event coverage, and sponsorship of daily and weekly reports. Endpoints.
Now, life science marketers can produce branded content in the caliber readers expect from Endpoints. Led by Kari Abitbol, our new Head of Advertising and Marketing Programs, the Endpoints Studio team develops measurable campaigns based on our first party data.
Our lineup includes Studio FSP and Studio FSP +, an enhancement of our long-standing sponsored posts with articles written by our Studio team – with an opportunity to capture leads. Studio FSP and FSP + benefit from the same exclusive promotion on our email reports, our home page and our news feeds. We’re also introducing Studio webinars, which run like custom and editorial webinars but are scheduled exclusively by our Studio team, and E-blast +, which features a landing page created and hosted by Endpoints and designed for high conversion.
What exactly makes Endpoints Studio different? Discover the new workshop website to learn more about our products, our topics (which range from cell and gene therapy to pharmaceutical marketing) and how we use our own data to deliver better content to our readers and stronger results for our advertisers. And soon, you’ll see case studies of how we learn from our own Studio programs to generate even greater impact.
In 2021, our commitment was to go further and further. We launched four weekly reports – Manufacture of terminals, Weekly endpoints, FDA + assessment criteria and the new one released MarketingRx endpoints – and delivered breaking news that fueled a wave of new subscribers. Our active daily email readership approaches 125,000 subscribers as we close the year. We have grown our team from 22 full-time employees in January to 35 full-time employees (and that’s not the end of it) to mature and support these large-scale initiatives.
As we look to the year ahead, we are so grateful for the continued support from readers, subscribers and sponsors that has catapulted us from a small media company into a thriving force whose work is seen daily by the leaders of the media. 25 largest pharmaceutical companies and thousands of biotech startups around the world. And we’re just getting started.
Stay tuned for more Kari Endpoints Studio updates next year and contact Revenue Director Mike Peck ([email protected]) with Studio planning and pricing inquiries.